Improving CAR T cell therapy against malignancies through gene knock-down/out strategies: a systematic review
Abstract Background CAR T cells still face numerous obstacles in treating hematologic and solid malignancies. Although gene editing technologies have improved CAR T cell therapy, there are currently no systematic reviews to broadly address preclinical and clinical outcomes of gene-edited CAR T cells...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-12-01
|
| Schriftenreihe: | Cancer Cell International |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12935-025-04090-5 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
